Ethiqa XR (buprenorphine) Extended-Release Injectable Suspension, 1.3mg/mL, CIII (C3) 3 mL Vial and 2 more items

The University of Virginia awarded contract A207_PO-0458104 to WA Butler Company doing business as Covetrus North America, LLC on July 15, 2026, with a cumulative contract value of $444. The contract encompasses the delivery of pharmaceutical and veterinary medical supplies to Katherine Saldana at the University of Virginia. The three line items include Ethiqa XR (buprenorphine) Extended-Release Injectable Suspension at 1.3 milligrams per milliliter in a 3-milliliter vial ($422.45); Altalube Ointment, a lubricant eye ointment in a 3.5-gram tube ($6.25); and Veterinary Surgical Adhesive in a 2-milliliter bottle ($15.58).

As a single purchase order, this contract represents a one-time transactional award rather than a recurring services agreement. The products delivered indicate the University of Virginia's procurement of specialized pharmaceutical and veterinary supplies through Covetrus North America, LLC, a distributor of veterinary and animal health products. No annual value or extended performance period is specified in the contract documentation, suggesting this represents a discrete supply delivery to support University of Virginia operations.